Nanother intersects biomedical, health and nano industries, and R&D sits at the interface of chemical, biological and physical sciences and engineering. The main Nanother objective is therefore based on the integration of 5 key elements of current technology:
Nanoparticle functionalisation technology,
contrast agent & specific antibody diagnostic techniques & imaging equipment,
novel drug-delivery & activation systems
new uses for electromagnetic based technology and medical equipment.
Another important innovation is RNAi technology, and the objective is to investigate the successful formulation and application of nanocarriers including siRNA as the therapeutic agent.